Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
2011 · Breast Cancer Research · 224 citations
https://doi.org/10.1186/bcr2907
M
Michal Mego
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
378
Papers
6.1K
Citations
44
h-index
121
i10-index
Michal Mego is an academic researcher from Slovak Academy of Sciences. The author has contributed to research in topics: Testicular diseases and treatments & Cancer Cells and Metastasis & Sarcoma Diagnosis and Treatment. The author has an h-index of 44, co-authored 322 publications.
ORCID: 0000-0002-6511-6827Papers by this author
worksEpithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer
2012 · Molecular Cancer Therapeutics · 223 citations
https://doi.org/10.1158/1535-7163.mct-12-0460
Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors
2015 · Annals of Oncology · 162 citations
https://doi.org/10.1093/annonc/mdv574
Relationship Between Lymphocytopenia and Circulating Tumor Cells as Prognostic Factors for Overall Survival in Metastatic Breast Cancer
2012 · Clinical Breast Cancer · 123 citations
https://doi.org/10.1016/j.clbc.2012.04.004
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
2014 · Breast Cancer Research · 122 citations
https://doi.org/10.1186/s13058-014-0440-8
<sup>18</sup>F-FDG PET/CT Findings and Circulating Tumor Cell Counts in the Monitoring of Systemic Therapies for Bone Metastases from Breast Cancer
2010 · Journal of Nuclear Medicine · 58 citations
https://doi.org/10.2967/jnumed.110.076455
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat